Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.07 USD
−1.78 M USD
0.00 USD
12.23 M
About XTL BIO
Sector
Industry
CEO
Shlomo Spokone Shalev
Website
Headquarters
Ramat Gan
Founded
1993
FIGI
BBG000F1JVP4
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.